FDA Inspection 1101928 — University of North Carolina at Chapel Hill (UNC) RDRC

University of North Carolina at Chapel Hill (UNC) RDRC — FEI 3015197472

The FDA completed an inspection of University of North Carolina at Chapel Hill (UNC) RDRC on September 16, 2019 in Chapel Hill, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 16, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chapel Hill, NC (United States)

Additional Details

Radioactive Drug Research Committee

Citations

IDCFRDescription
1795821 CFR 361.1(c)(2)Signatures of RDRC Chairman
1796221 CFR 361.1(c)(2)Numerical votes not in the minutes of any RDRC meetings